20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
- CVS Health Corp (NYSE:CVS) agreed to acquire Oak Street Health (NYSE:OSH) in an all-cash transaction at $39 per share, or approximately $10.6 billion.
- Oak Street Health is a multi-payor, value-based primary care company, employing approximately 600 primary care providers and has 169 medical centers across 21 states.
- Related: CVS Health Continues M&A Spree, As It Is Close To $10B Bet For Oak Street Health
- "Combining Oak Street Health's platform with CVS Health's unmatched reach will create the premier value-based primary care solution," said CVS Health President and CEO Karen Lynch.
- Following the close of the transaction, Pykosz will continue to lead Oak Street Health, which will become part of CVS Health's recently formed Health Care Delivery organization.
- CVS Health and Oak Street Health anticipate that the transaction will close in 2023.
- By 2026, Oak Street Health will have over 300 centers, each of which has the potential to contribute $7 million of Oak Street Health Adjusted EBITDA at maturity, representing more than $2 billion of Oak Street Health embedded Adjusted EBITDA at that time.
- Additionally, CVS Health projects more than $500 million in synergy potential over time.
- CVS Health reported Q4 sales of $83.85 billion, up 9.5% Y/Y, driven by growth across all segments, beating the consensus of $76.21 billion.
- Operating income decreased 41.3% for FY22 to $7.75 billion, primarily due to $5.8 billion of opioid litigation charges and a $2.5 billion loss on assets held for sale related to the write-down of the company's Omnicare long-term care business.
- Guidance: CVS Health projects 2023 Adjusted EPS of $8.70-$8.90 versus the consensus of $8.86. CVS Health is now targeting 2024 Adjusted EPS of approximately $9.00, growing to approximately $10.00 in 2025.
- Price Action: CVS shares are up 1.92% at $87.63 during the premarket session on the last check Wednesday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!